[go: up one dir, main page]

MX2012002089A - Composiciones alcoholicas que tienen un riesgo reducido de acetaldehidemia. - Google Patents

Composiciones alcoholicas que tienen un riesgo reducido de acetaldehidemia.

Info

Publication number
MX2012002089A
MX2012002089A MX2012002089A MX2012002089A MX2012002089A MX 2012002089 A MX2012002089 A MX 2012002089A MX 2012002089 A MX2012002089 A MX 2012002089A MX 2012002089 A MX2012002089 A MX 2012002089A MX 2012002089 A MX2012002089 A MX 2012002089A
Authority
MX
Mexico
Prior art keywords
acetaldehydeemia
reduced risk
alcoholic compositions
compositions
alcoholic
Prior art date
Application number
MX2012002089A
Other languages
English (en)
Inventor
Anthony Czarnik
Jeffrey Mckinney
Original Assignee
Protia Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protia Llc filed Critical Protia Llc
Publication of MX2012002089A publication Critical patent/MX2012002089A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12CBEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
    • C12C12/00Processes specially adapted for making special kinds of beer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12GWINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00Preparation of other alcoholic beverages
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12GWINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00Preparation of other alcoholic beverages
    • C12G3/04Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
    • C12G3/05Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Alcoholic Beverages (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)

Abstract

La presente invención proporciona bebidas y composiciones farmacéuticas que contienen un alcohol deuterizado de acuerdo con la Fórmula 1, y proporciona métodos para su elaboración y uso. Se espera que las composiciones de la invención disminuyan algunos de los efectos colaterales negativos asociados con el consumo de alcohol, tales como resaca y rubefacción facial.
MX2012002089A 2009-08-21 2010-08-20 Composiciones alcoholicas que tienen un riesgo reducido de acetaldehidemia. MX2012002089A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US27487509P 2009-08-21 2009-08-21
US28086009P 2009-11-09 2009-11-09
US28352409P 2009-12-04 2009-12-04
US12/777,238 US8658236B2 (en) 2009-08-21 2010-05-10 Alcoholic compositions having a lowered risk of acetaldehydemia
PCT/US2010/046211 WO2011022682A1 (en) 2009-08-21 2010-08-20 Alcoholic compositions having a lowered risk of acetaldehydemia

Publications (1)

Publication Number Publication Date
MX2012002089A true MX2012002089A (es) 2012-07-03

Family

ID=43605849

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012002089A MX2012002089A (es) 2009-08-21 2010-08-20 Composiciones alcoholicas que tienen un riesgo reducido de acetaldehidemia.

Country Status (32)

Country Link
US (6) US8658236B2 (es)
EP (1) EP2467465B1 (es)
JP (1) JP5862965B2 (es)
KR (1) KR101462740B1 (es)
CN (2) CN102471742B (es)
AP (1) AP3676A (es)
AU (1) AU2010284051B2 (es)
BR (1) BR112012003560A8 (es)
CA (1) CA2771166C (es)
CL (1) CL2012000448A1 (es)
CO (1) CO6511227A2 (es)
CY (1) CY1119041T1 (es)
DK (1) DK2467465T3 (es)
EA (1) EA023867B1 (es)
ES (1) ES2635730T3 (es)
GE (1) GEP20146057B (es)
HR (1) HRP20171225T1 (es)
HU (1) HUE036124T2 (es)
IL (1) IL218201A (es)
LT (1) LT2467465T (es)
ME (1) ME02866B (es)
MX (1) MX2012002089A (es)
MY (1) MY156177A (es)
NZ (1) NZ598452A (es)
PL (1) PL2467465T3 (es)
PT (1) PT2467465T (es)
RS (1) RS56120B1 (es)
SG (1) SG178521A1 (es)
SI (1) SI2467465T1 (es)
SM (1) SMT201700397T1 (es)
WO (1) WO2011022682A1 (es)
ZA (1) ZA201202075B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3135656T3 (en) 2011-06-20 2019-04-23 H Lundbeck As DEUTERATED 1-PIPERAZINO-3-PHENYL INDANES FOR TREATMENT OF schizophrenia
US20140079857A1 (en) * 2012-04-05 2014-03-20 Anheuser-Busch, Llc Methods for decarbonating fermented liquids
HK1212232A1 (en) 2012-09-18 2016-06-10 Auspex Pharmaceuticals, Inc. Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
US9713330B1 (en) 2013-03-15 2017-07-25 Deuteria Agrochemicals, Llc Deuterium-enriched aldehydes
US9023336B2 (en) 2013-03-15 2015-05-05 Deuterra Agrochemicals, LLC Deuterium-enriched aldehydes
WO2016044473A1 (en) * 2014-09-16 2016-03-24 Robert Brocia Energy drinks and other nutritional aids derived from agave-based spirits
CN114403335A (zh) * 2014-12-09 2022-04-29 以西结·戈兰 酒精饮料替代品
SG11201706959TA (en) 2015-03-06 2017-09-28 Auspex Pharmaceuticals Inc Methods for the treatment of abnormal involuntary movement disorders
KR20170032815A (ko) 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
US10289381B2 (en) * 2015-12-07 2019-05-14 Motorola Mobility Llc Methods and systems for controlling an electronic device in response to detected social cues
KR20200004827A (ko) 2017-04-27 2020-01-14 듀테리아 비버리지스, 엘엘씨 D2로부터 중수소화 에탄올을 제조하는 방법
EP3615204A4 (en) 2017-04-27 2020-12-09 Deuteria Beverages LLC PROCESS FOR PREPARING DEUTERATED ETHANOL FROM D2O
CN109330632B (zh) * 2018-11-09 2023-09-29 上海导向医疗系统有限公司 活检旋切装置
WO2020114853A1 (en) 2018-12-03 2020-06-11 H. Lundbeck A/S Prodrugs of 4-((1r,3s)-6-chloro-3-phenyl-2,3-dihydro-1h-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1/r,3s)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1h-inden-1-yl)-2,2-dimethy-1-(methyl-d3)piperazine
WO2020175519A1 (ja) * 2019-02-26 2020-09-03 つばめBhb株式会社 成形焼結体および成形焼結体の製造方法
US10582716B1 (en) 2019-06-14 2020-03-10 Lennham Pharmaceuticals, Inc. Deuterated caffeine and uses thereof
EP4051432B8 (en) 2019-10-29 2025-07-30 TMRW Life Sciences, Inc. Apparatus to facilitate transfer of biological specimens stored at cryogenic conditions
US11817187B2 (en) 2020-05-18 2023-11-14 TMRW Life Sciences, Inc. Handling and tracking of biological specimens for cryogenic storage
USD963194S1 (en) 2020-12-09 2022-09-06 TMRW Life Sciences, Inc. Cryogenic vial carrier
CA3200508A1 (en) 2020-12-10 2022-06-16 TMRW Life Sciences, Inc. Specimen holder with wireless transponder for attachment to specimen collection body
WO2022155225A1 (en) 2021-01-13 2022-07-21 TMRW Life Sciences, Inc. Systems, apparatus and methods to pick and/or place specimen containers
US12194046B2 (en) 2021-03-09 2025-01-14 Lennham Pharmaceuticals, Inc. D9-caffeine compositions and uses thereof
US12527318B2 (en) 2021-10-08 2026-01-20 TMRW Life Sciences, Inc. Systems, apparatus and methods to pick and/or place specimen containers

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5156408A (en) * 1974-11-08 1976-05-18 Piasu Chem Co Karubonsanno jusuisokaesuteruno seizohoho
DE3413085A1 (de) 1984-04-06 1985-10-24 Henkell & Co, 6200 Wiesbaden Verfahren zum herabsetzen des alkoholgehalts alkoholhaltiger getraenke, insbesondere wein und schaumwein
US4612196A (en) 1984-08-23 1986-09-16 Miller Brewing Company Preparation of low alcohol beverages by reverse osmosis
US5223269A (en) * 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension
HU208084B (en) * 1991-10-31 1993-08-30 Hyd Kutato Fejlesztoe Kft Process for producing compositions suitable for curing tumorous diseases
JPH05156408A (ja) * 1991-11-29 1993-06-22 Nippon Steel Corp 溶接性に優れた高強度マルテンサイトステンレス鋼とその製造方法
DE4343838C2 (de) * 1993-12-22 1998-07-09 Lohmann Therapie Syst Lts Deuteriertes Arzneimittel in transdermaler Applikation und Verfahren zu seiner Herstellung
WO1995018545A1 (en) 1994-01-06 1995-07-13 Hyd Kutató-Fejlesztó Ktf. Food products for preventing development of diseases and process for preparing same
CN1143308A (zh) * 1994-01-06 1997-02-19 Hyd探索发展有限公司 预防疾病发生的食品及其制备方法
ES2293638T3 (es) 1994-03-25 2008-03-16 Isotechnika, Inc. Mejora de la eficacia de farmacos por deuteracion.
GB2293100A (en) * 1994-09-15 1996-03-20 Medeva Europ Ltd Pharmaceutical compositions with deuterium oxide
KR100387229B1 (ko) 1995-11-01 2003-08-21 삼성전자주식회사 영상부호화장치
US6376531B1 (en) * 1998-11-13 2002-04-23 Rupert Charles Bell Method of treatment using deuterium compounds
TW200413273A (en) 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
DE10362026B4 (de) 2003-12-19 2009-01-08 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Verwendung von Palatinose zur Verbesserung der Lagerungsstabilität eines bierähnlichen Erfrischungsgetränkes
EP1846546B1 (en) * 2005-02-08 2011-04-13 Woodford Associates Limited Alcoholic beverage enriched with 1h216o
AU2006299424A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties
US7713773B2 (en) * 2005-11-02 2010-05-11 Solopower, Inc. Contact layers for thin film solar cells employing group IBIIIAVIA compound absorbers
US20080301122A1 (en) * 2007-05-31 2008-12-04 Amadeus S.A.S. Searching techniques
US20090046823A1 (en) * 2007-08-14 2009-02-19 Texas Instruments Incorporated Neutron generating device

Also Published As

Publication number Publication date
US20160137959A1 (en) 2016-05-19
US11298317B2 (en) 2022-04-12
AU2010284051B2 (en) 2014-12-04
US8658236B2 (en) 2014-02-25
ES2635730T3 (es) 2017-10-04
US10047330B2 (en) 2018-08-14
IL218201A0 (en) 2012-04-30
EP2467465A4 (en) 2013-09-25
JP5862965B2 (ja) 2016-02-16
ME02866B (me) 2018-04-20
KR101462740B1 (ko) 2014-11-17
CA2771166C (en) 2015-02-24
CL2012000448A1 (es) 2012-08-31
AU2010284051A1 (en) 2012-03-08
SG178521A1 (en) 2012-04-27
US20180030394A1 (en) 2018-02-01
WO2011022682A1 (en) 2011-02-24
EA023867B1 (ru) 2016-07-29
EP2467465B1 (en) 2017-06-07
SMT201700397T1 (it) 2017-09-07
CA2771166A1 (en) 2011-02-24
PL2467465T3 (pl) 2017-11-30
KR20120053510A (ko) 2012-05-25
US20150011651A1 (en) 2015-01-08
NZ598452A (en) 2012-12-21
HUE036124T2 (hu) 2018-06-28
EA201290097A1 (ru) 2012-08-30
MY156177A (en) 2016-01-15
HK1171245A1 (en) 2013-03-22
CN103300449B (zh) 2015-05-06
US10731116B2 (en) 2020-08-04
CN102471742B (zh) 2013-05-29
LT2467465T (lt) 2017-11-27
CO6511227A2 (es) 2012-08-31
US20190062680A1 (en) 2019-02-28
CN102471742A (zh) 2012-05-23
IL218201A (en) 2015-09-24
JP2013502227A (ja) 2013-01-24
PT2467465T (pt) 2017-09-11
AP2012006133A0 (en) 2012-02-29
ZA201202075B (en) 2013-08-28
GEP20146057B (en) 2014-03-10
HRP20171225T1 (hr) 2017-10-20
SI2467465T1 (sl) 2017-09-29
US20110046236A1 (en) 2011-02-24
US9044423B2 (en) 2015-06-02
AP3676A (en) 2016-04-16
DK2467465T3 (en) 2017-09-11
BR112012003560A8 (pt) 2020-12-01
BR112012003560A2 (pt) 2020-10-27
US20210038511A1 (en) 2021-02-11
EP2467465A1 (en) 2012-06-27
CN103300449A (zh) 2013-09-18
RS56120B1 (sr) 2017-10-31
CY1119041T1 (el) 2018-01-10
US9732311B2 (en) 2017-08-15

Similar Documents

Publication Publication Date Title
MX2012002089A (es) Composiciones alcoholicas que tienen un riesgo reducido de acetaldehidemia.
CO6480918A2 (es) Antagonistas policíclicos de receptores de ácido lisofosfatídico.
GT201200165A (es) Triazolopiridinas
ECSP13013074A (es) Nuevos derivados de piridina
MX2020005645A (es) Compuestos de benzaldehido sustituidos y metodos para su uso en incrementar la oxigenacion del tejido.
CU20140009A7 (es) Indazoles
CO6410279A2 (es) Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente.
CR20130671A (es) Antagonistas de trpv4
CR20120283A (es) Inhibidor de bromodominio de benzodiazepina
CR20120264A (es) Compuestos
CR20140071A (es) Nuevos compuestos de 4-piperidinilo para uso como inhibidores de la tankirasa
ECSP12012174A (es) Derivados de n-(imidazopirimidin-7-il)-heteroarilamida y su uso como inhibidores de pde10a
ECSP11011517A (es) Compuestos antivirales
UY31922A (es) Compuestos
MX2020008031A (es) Composiciones y metodos para reducir el contenido de alcohol en sangre.
CO6290655A2 (es) Inhibidors heterociclicos de estearoil-coa-desaturasa
UY32937A (es) Compuestos y composiciones como moduladores de la actividad de gpr119
IN2014DN02926A (es)
CL2010001566A1 (es) Compuesto derivado de piperidinilo, modulador de la actividad de los receptores de la quimiocina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades inflamatorias, alergicas, autoinmune.
CR20130318A (es) Nuevos compuestos de benzodioxol-piperazina
ECSP12011837A (es) Derivados de pirazol que modulan la estearoil-coa-desaturasa
SV2011003784A (es) Nifurtimox para el tratamiento de enfermedades causadas por trichomonadida
BR112014013033A2 (pt) composição microbicida, composição de barra de sabão, método para fornecer um efeito microbicida para a pele e uso da composição
AR084169A1 (es) Combinacion que comprende un derivado de la familia de las combretastatinas y cetuximab
MX2013007504A (es) Composiciones y metodos de uso de formas cristalinas de analogos de wortmanina.

Legal Events

Date Code Title Description
FG Grant or registration